Tumor cells promote fibrosis by persistently releasing inflammatory factors like IL-1, TGF-β1, TNF, and IL-6, which activate the NF-κB and JAK/STAT signaling pathways, inducing fibroblast differentiation into a pro-inflammatory phenotype or myofibroblasts. This evidence concerns the gene NFKB1 and neoplasm.